
Allovir, Inc. (ALVR) Stock Forecast & Price Target
Allovir, Inc. (ALVR) Analyst Ratings
Based on 7 analyst ratings
Hold
Strong Buy 0%
Buy 43%
Hold 29%
Sell 29%
Strong Sell 0%
Allovir, Inc. (ALVR) has been analyzed by 7 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 29% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Allovir, Inc. and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Allovir, Inc. and is not a guaranteed prediction by Public.com or investment advice.
Allovir, Inc. (ALVR) Analyst Forecast & Price Prediction
Get the latest Allovir, Inc. (ALVR) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Allovir, Inc. (ALVR)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Allovir, Inc. (ALVR) Forecast
Analysts have given Allovir, Inc. (ALVR) a Hold based on their latest research and market trends.
According to 7 analysts, Allovir, Inc. (ALVR) has a Hold consensus rating as of Aug 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $13.14, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $13.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.